Photo via CBS News

Companies illegally selling unapproved Eli Lily weight loss drug Retatrutide online

Read the original at CBS News ↗
Cite

Companies illegally selling unapproved Eli Lily weight loss drug Retatrutide online. (2026, September 17). CBS News. https://www.cbsnews.com/video/companies-illegally-selling-unapproved-weight-loss-drug-online/

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

CBS News · collected 2026-09-17

Quick Summary

CBS News uncovered that companies are selling Retatrutide, an unapproved weight loss drug currently in clinical trials by Eli Lilly, illegally through online platforms to customers in the United States. Investigative reporter Daniel Gilbert reported on this issue.
Written by AI on 2026-09-17, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

A CBS News investigation revealed that unapproved Eli Lilly weight loss drug Retatrutide, which is still in clinical trials, is being marketed and illegally sold to U.S. customers online by various companies. The report highlights significant regulatory concerns as Retatrutide has not yet been approved for public use, raising safety issues for consumers purchasing it from unverified sources.

Written for “Illegal Sale of Retatrutide” on 2026-10-31, grounded in this article and the 0 other(s) covering the same event.

Story

📰 Illegal Sale of Retatrutide
Health · 1 article(s) covering the same event.

Compared with similar articles

This article reads unscored and hedges 0% of its claims. Each row says how that neighbour differs.
Washington Examiner
⚖️ Leans right Hedges 0 of 28 claims Outlet record 70/100
“While both articles discuss the illegal sale of Retatrutide, Article A focuses on CBS News' investigation finding companies selling it online to U.S. clients, while Article B highlights the drug being sold through TikTok, medical spas, and mail to teenagers.”
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
2
sentences that state something as happening or true
Uncertain
0%
0 of 2 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
66/100
CBS News's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
1
Health
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-09-17 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

CBS News · 4280 article(s) · 6 correction(s) detected
Running correction rate · 6 correction(s)

Who wrote this

No reporter is named on this article.

Topics

CBS News Eli Lily Retatrutide U.S. online

Subjects

CBS News ORG · 2× Eli Lily ORG · 2× Daniel Gilbert PERSON · 1× U.S. GPE · 1×

Narrative

Companies illegally selling unapproved Eli Lily weight loss drug Retatrutide online Retatrutide, an experimental weight loss drug still undergoing clinical trials at Eli Lily, is being marketed online and illegally sold to U.S. clients, a CBS News investigation found.
framing: assertive · carried by 1 article(s) · first seen 2026-09-17

Claims (2 extracted, 0 hedged)

Companies illegally selling unapproved Eli Lily weight loss drug Retatrutide online Retatrutide, an experimental weight loss drug still undergoing clinical trials at Eli Lily, is being marketed online and illegally sold to U.S. clients, a CBS News investigation found. asserted
investigation → sell → clients
CBS News investigative reporter and producer Daniel Gilbert has the story. asserted
Gilbert → have → story
💬Give feedback
🕘History 🎫Support